Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA)
Conditions
Interventions
- DRUG: TR-701 FA for injection, 200 mg/vial
- DRUG: TR-701 FA tablets
Sponsor
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)